XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Stopped Futility reasons after Independent Data Monitoring Committee interim analysis

Conditions

• Biliary Tract Cancer

Interventions

• DRUG: becatecarin
• DRUG: 5-Fluorouracil Plus Leucovorin

Sponsor

Helsinn Healthcare SA